The discovery of ugd and galU genes reveals how Proteus mirabilis evades last-resort antibiotics while enhancing its ability to cause disease.
In the endless arms race between humans and bacteria, Proteus mirabilis has long puzzled scientists with its remarkable ability to withstand polymyxin B—a powerful antibiotic of last resort. For years, the mechanisms behind this bacterial superpower remained mysterious. Now, groundbreaking research has uncovered two key genes that not only explain this antibiotic resistance but also reveal how the bacterium spreads infection and causes disease 1 4 .
This discovery opens new pathways in our understanding of bacterial warfare and potential approaches to combat stubborn infections.
Antibiotic resistance is a growing global health threat, with multidrug-resistant bacteria causing difficult-to-treat infections.
Two genes, ugd and galU, play crucial roles in both antibiotic resistance and virulence of Proteus mirabilis.
Proteus mirabilis is a Gram-negative, rod-shaped bacterium commonly found in soil, water, and the human intestinal tract. While often harmless in the gut, it becomes a formidable pathogen when it travels to the urinary system, where it causes approximately 90% of all Proteus-related infections 6 .
This microorganism is particularly notorious for complicating urinary tract infections in catheterized patients and individuals with long-term urinary devices 6 .
Proteus mirabilis can transform from short, typical bacterial cells into elongated, hyper-flagellated "swarmer" cells that move collectively across surfaces in a coordinated manner. This unique capability allows it to spread rapidly along urinary catheters and tissue surfaces, creating characteristic bull's-eye patterns on laboratory media 6 .
The bacterium generates large amounts of urease, an enzyme that breaks down urea into ammonia. This alkalinizes urine and promotes the formation of struvite stones, which can obstruct urinary flow and provide hiding places for bacteria to evade antibiotics 6 .
Polymyxin B belongs to a class of cationic antimicrobial peptides that serve as crucial last-line defenses against multidrug-resistant Gram-negative bacteria. These antibiotics work by attaching to and disrupting lipopolysaccharide (LPS) molecules in the bacterial outer membrane. While some bacteria develop resistance through acquired mutations, others like Proteus mirabilis are naturally resistant to these drugs—a phenomenon that has long intrigued scientists 8 .
Researchers employed an innovative genetic technique called Tn5 transposon mutagenesis to identify which genes might affect Proteus mirabilis's susceptibility to polymyxin B. This process involves randomly inserting foreign DNA sequences into bacterial genes and observing which mutations alter the bacterium's properties 1 .
These enzymes play essential roles in creating and modifying lipopolysaccharide (LPS) molecules—critical components of the bacterial outer membrane that serve as the first point of contact with antibiotics and host defenses 1 .
| Strain Name | Genotype/Characteristics | Source/Reference |
|---|---|---|
| N2 | Wild type Proteus mirabilis | Clinical isolate |
| ns2 | N2 derivative; ugd Tn5-mutagenized mutant | This study |
| ns5 | N2 derivative; galU Tn5-mutagenized mutant | This study |
| dG1 | N2 derivative; galU knockout mutant | This study |
| dU2 | N2 derivative; ugd knockout mutant | This study |
| dA10 | N2 derivative; rppA knockout mutant | 1 |
The team created specific knockout mutants of both ugd and galU genes using genetic engineering techniques, allowing them to study the bacteria without these functional genes 1 .
Researchers cultured the bacteria on special agar plates designed to observe swarming behavior, measuring migration distance and pattern formation 1 .
| Characteristic | Wild-type P. mirabilis | ugd mutant | galU mutant | Complemented Mutants |
|---|---|---|---|---|
| Polymyxin B Resistance | Highly resistant | Extremely sensitive | Extremely sensitive | Resistance restored |
| Swarming Motility | Normal swarming | Significantly impaired | Significantly impaired | Mostly restored |
| Hemolysin Production | Normal levels | Reduced expression | Reduced expression | Levels restored |
| Cell Invasion Ability | Normal invasion | Reduced ability | Reduced ability | Ability restored |
The fact that complementation restored most wild-type characteristics provided compelling evidence that the observed defects directly resulted from the loss of these specific genes rather than secondary mutations 1 4 .
Researchers discovered that polymyxin B exposure actually induces the expression of Ugd and GalU through RppA—suggesting the bacteria sense the antibiotic threat and activate defense mechanisms. When either ugd or galU was disrupted, this activated RpoE (a stress-response sigma factor), which in turn inhibited FlhDC (a master regulator of flagella production) and hemolysin expression 1 4 .
This research revealed that antibiotic resistance and virulence are intimately connected in Proteus mirabilis. The same genes that help modify LPS to repel polymyxin B also contribute to proper swarming motility and toxin production. This connection makes biological sense—bacteria that successfully colonize a host need to coordinate multiple capabilities: movement to spread, adhesion to stick to tissues, toxin production to damage host cells, and defense mechanisms to withstand immune attacks 1 4 .
Recent studies have further illuminated this complex regulatory network. A 2025 investigation of 91 Proteus mirabilis isolates found that biofilm formation ability and swarming motility are inversely correlated, with bacteria potentially switching between these states at different stages of infection. Strong swarming was associated with higher frequency of the hlyA gene (encoding hemolysin), while the rsmA gene acted as a repressor of swarming 5 .
| Reagent/Tool | Function/Application | Example Use in This Study |
|---|---|---|
| Tn5 Transposon Mutagenesis | Random insertion of foreign DNA to disrupt genes and identify function | Identification of ugd and galU as affecting polymyxin B resistance 1 |
| Knockout Mutants | Targeted deletion of specific genes to study their function | Creation of ugd and galU knockout mutants to characterize phenotypic changes 1 |
| Complementation Plasmids | Vectors containing functional genes to restore activity in mutants | Verification that observed defects were specifically due to the missing genes 1 |
| Lipopolysaccharide (LPS) Extraction | Isolation of LPS from bacterial membranes for structural and functional analysis | Analysis of how LPS structure changes in mutants and affects antibiotic susceptibility 3 |
| Swarming Motility Assays | Specialized agar plates to observe and measure bacterial surface migration | Evaluation of how ugd and galU mutations impair swarming capability 1 |
The discovery of Ugd and GalU's roles in polymyxin B resistance, swarming motility, and virulence expression opens several promising avenues for future research and potential therapeutic development:
Understanding the genetic basis of virulence and resistance could lead to improved diagnostic tests that identify particularly dangerous strains in clinical settings 5 .
Further exploration of how RppA, RpoE, and FlhDC interact to coordinate resistance and virulence could reveal additional vulnerable points in the bacterial defense system 1 .
The characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase in Proteus mirabilis demonstrates how fundamental biochemical pathways—once thought to be merely housekeeping functions—can play crucial roles in antibiotic resistance and virulence. This research not only solves a long-standing mystery about how this bacterium evades polymyxin B but also reveals the elegant interconnectedness of bacterial defense systems.
As we continue to face the growing threat of antibiotic-resistant infections, such insights into bacterial genetics and physiology become increasingly valuable. By understanding exactly how pathogens like Proteus mirabilis withstand our best drugs and spread through our tissues, we pave the way for smarter, more targeted approaches to combat infectious diseases—potentially saving countless lives in the ongoing battle against resistant bacteria.